天然杀手T细胞在喘发病和治疗中的作用:老问题和未来的前景
Akter Dilroba1, Asia Fanella1, Tommaso Pianigiani1
1UOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
ERJ open research
|October 29, 2025
概括
自然杀手T细胞 (NKT细胞) 在喘病变和呼吸道过敏反应中起着关键作用. 先进的技术澄清了NKT细胞在细胞因子分泌中的参与以及与其他免疫细胞的相互作用.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 自然杀伤性T细胞 (NKT细胞) 呈现出先天性和适应性免疫的特征.
- NKT细胞已涉及喘病原和诱导气道过敏反应 (AHR).
- 过去的研究由于分析方法和患者队列不一致,导致有争议的发现.
研究的目的:
- 审查和综合目前对NKT细胞在喘中的作用的理解.
- 讨论NKT细胞表型的进展及其对研究的影响.
- 探索NKT细胞对AHR和喘病理学的贡献机制.
主要方法:
- 关于喘中NKT细胞的最新科学文献的综述.
- 分析使用先进细胞表型化技术的研究.
- 检查来自小鼠模型和人类受试者的数据.
主要成果:
- 改进的表型化技术已经澄清了NKT细胞的功能.
- NKT细胞通过细胞因子分泌促进AHR诱导.
- 在小鼠模型中缺少NKT细胞可以防止AHR,并降低乙氨基细胞数量.
- NKT细胞与先天性 (树突细胞) 和适应性 (Tregs) 免疫细胞相互作用.
- NKT细胞的细胞因子生产因微环境而异.
- 与外周血液相比,在支气管支气管洗中发现了较高的NKT细胞计数.
结论:
- NKT细胞是喘病原体的核心.
- 用单克隆抗体向NKT细胞相关的细胞因子 (例如IL-5,IL-13) 是一个有前途的治疗策略.
- 需要进一步的研究,以充分阐明NKT细胞在喘中的功能.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K


